Skip to main content
Premium Trial:

Request an Annual Quote

Holmes Takes the Stand

Elizabeth Holmes, the founder and former CEO of Theranos, has taken the stand after the prosecution rested its case in her criminal trial, CNN reports.

The trial began in September, and prosecutors have alleged that she defrauded investors, as the Wall Street Journal reports. Theranos, which was once valued at $9 billion, said it could run a series of clinical blood tests from a small about of blood from a finger prick, but that ran into trouble following a string of stories in the Journal that questioned its ability to conduct those tests. A regulatory inspection further uncovered numerous issues with a Theranos lab and eventually barred Holmes and Ramesh 'Sunny' Balwani, the former president of Theranos, from owning or operating a lab for a period of time. The collapse of the company also sparked criminal indictments for Holmes and Balwani.

As the Journal now reports, the prosecution's case has included weeks of testimony from investors, employees, and scientists as well as evidence that Theranos altered documents to suggest prominent companies had endorsed the technology.

CNN adds that whether Holmes would testify was a main question of the trial, adding that she first took the stand last Friday to give her account. According to CNN, one of the first questions her attorney asked her was whether she believe that Theranos could run all the blood tests, and she said she did.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.